Tag Archives: RESORCE trial

Bayer’s Stivarga Results Show Promise in Fighting Liver Cancer

BAYER AG (Leverkusen DEU) now has Phase 3 results which suggest its Stivarga product is an effective treatment for a common form of liver cancer known as hepatocellular carcinoma (HCC)…. Read more »